Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Prism Medico And Pharmacy has furnished a copy of compliance certificate issued by the RTA for the quarter ended 30th September, 2022.
The above information is a part of company’s filings submitted to BSE.